Raymond James reiterates Outperform on CME Group, maintains $320 target

0 min read | Published on 03 Jul 2026, 01:00 AM |Updated on 03 Jul 2026, 01:00 AM

Reviewed by

Radhika SScanX News Team

Key Highlights

Raymond James analyst Patrick O'Shaughnessy reaffirmed an Outperform rating for CME Group and maintained a $320 price target, signaling continued confidence in the stock.

*this image is generated using AI for illustrative purposes only.

Raymond James analyst Patrick O'Shaughnessy has reaffirmed an Outperform rating for CME Group. The firm maintained a $320 price target on the stock.

Rating and Price Target

The rating reiteration comes as the analyst holds a positive outlook on the exchange operator. The price target of $320 remains unchanged, indicating confidence in the company's future performance.

Metric	Value
Rating	Outperform
Price Target	$320

What specific factors are driving the analyst's confidence in CME Group's future performance?

How might recent market volatility impact CME Group's trading volumes and revenue?

What are the potential risks to achieving the $320 price target in the current economic environment?

Read Next Article

CME Group reports record June volume led by equity index surge

1 min read | Published on 02 Jul 2026, 05:53 PM |Updated on 02 Jul 2026, 06:09 PM

Reviewed by

Anirudha BScanX News Team

Add as a preferred
source on Google

Key Highlights

CME Group set a June record with 30.6 million contracts ADV, up 19% YoY, and recorded its second-highest Q2 volume at 29.8 million contracts. Equity index and agricultural products hit monthly records, with cryptocurrency ADV jumping 76%.

*this image is generated using AI for illustrative purposes only.

CME Group reported a record June average daily volume (ADV) of 30.6 million contracts, marking a 19% increase year-over-year. The derivatives marketplace also achieved its second-highest Q2 volume ever, with an ADV of 29.8 million contracts. The performance was driven by all-time monthly records in equity index and agricultural products, alongside broad-based growth across asset classes.

June 2026 Performance Highlights

Equity Index ADV surged 54% to a record 10.1 million contracts. Interest Rate ADV increased 17% to 13.6 million contracts, while Agricultural ADV rose 8% to a record 2.3 million contracts. Metals ADV grew 12% to 967,000 contracts, and Foreign Exchange ADV increased 6% to 1.2 million contracts. Cryptocurrency ADV jumped 76% to 334,000 contracts, representing a notional value of $10.7 billion.

Key Drivers in June

Micro products played a significant role in the volume growth. Micro E-mini Equity Index futures and options ADV reached 5.1 million contracts, representing 50% of overall Equity Index ADV. Record Micro E-mini Nasdaq-100 futures ADV hit 3.2 million contracts. Micro Gold futures ADV increased 33% to 342,000 contracts, and Micro Silver futures ADV soared 191% to 69,000 contracts.

Q2 2026 Quarterly Overview

Q2 ADV reached 29.8 million contracts. Equity Index ADV for the quarter stood at 8.6 million contracts, up 13%. Interest Rate ADV was 14.5 million contracts. Agricultural ADV increased 6% to 2.1 million contracts. Cryptocurrency ADV for the quarter rose 32% to 250,000 contracts, with a notional value of $13.7 billion.

Operational Metrics

BrokerTec overall average daily notional value (ADNV) increased 17% to $1.078 trillion in June. EBS Spot FX ADNV rose 7% to $68 billion. Customer average collateral balances for the rolling three-month period ending May 2026 were $150.7 billion for cash collateral and $173.4 billion for non-cash collateral.